$APOG

APOGEE ENTERPRISES, INC. (APOG) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. apog-20260805 0000006845 false 0000006845 2024-09-24 2024-09-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):

Apogee 21 (A21 Wine & Spirits) says it was selected as the successful bidder in a Chapter 11 court sale to buy Luca Mariano Distillery for $19.5m, including a 529-acre campus, assets, and about 6,600 ageing Bourbon barrels. The company plans to fund the purchase via $7m from investors, senior secured debt, and other financing, plus a $20m Series D. It also signed an LOI to buy Rod & Hammer’s whiskey brand and distillery in California.

APOGEE ENTERPRISES, INC. (APOG) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. apog-20260701 0000006845 false 0000006845 2024-11-04 2024-11-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):

APOGEE ENTERPRISES, INC. (APOG) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. apog-20260624 0000006845 false 0000006845 2024-01-10 2024-01-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securitie

Apogee’s Q1 FY2027 earnings call said net sales fell 1.1% to $343M as lower metals and glass volume was partly offset by pricing and mix. Adjusted EBITDA margin fell to 9.4% (from 9.9%); adjusted diluted EPS rose to $0.57. Backlog ended at $735M (+8% YoY). The company cited rising input costs, pricing actions, and softer glass conditions, and reiterated full-year guidance of $1.38B–$1.43B net sales and $2.70–$3.25 adjusted EPS. Apogee expects Kalwall acquisition revenue of ~$85M at ~15% adjusted

Apogee Enterprises reported Q1 adjusted diluted EPS of 57 cents, above the 45-cent consensus, on net sales of $342.7 million versus $333.8 million expected. The company cited pricing/product mix for offsetting a 1.1% volume decline. Operating income rose to $18.8 million; operating margin to 5.5%. It kept fiscal 2027 adjusted EPS guidance of $2.70–$3.25 and sales outlook of $1.38–$1.43 billion; Kalwall acquisition remains on track for early July. Shares were up 9.44% to $46.49.

APOGEE ENTERPRISES, INC. (APOG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a53026fy27q1results.htm EX-99.1 Document Press Release FOR RELEASE: June 26, 2026 APOGEE ENTERPRISES REPORTS FISCAL 2027 FIRST QUARTER RESULTS • First-quarter net sales of $342.7 million • First-quarter diluted EPS of $0.54 and adjusted diluted EPS of $0.57 • Pending Ka

TSX futures edged up Monday after three straight TSX declines, as investors weighed fragile U.S.-Iran peace talks. The TSX Composite fell 111.92 points to 34,857.34 Friday and was down 0.2% on the week. June futures rose 0.1%. Canada CPI rose 3.2% y/y in May. U.S. futures were mixed; Apogee Therapeutics jumped 48% after AbbVie agreed to buy it for about $10.9B.

Apogee (NASDAQ:APOG) will report earnings Friday before market open, according to the article. Last quarter, it posted revenue of $351.4 million, up 1.6% year over year, and beat analysts’ revenue and adjusted operating income estimates, with full-year revenue guidance above expectations. For this quarter, analysts expect revenue to fall 4.3% year over year.

US stocks opened with the Dow up about 0.5% and the S&P 500 up just over 0.3%, while the Nasdaq was flat as investors took profits in tech. Alphabet fell 5.5% after losing AI researcher Noam Shazeer to OpenAI. AbbVie agreed to buy Apogee for ~$10.9B cash ($135.11/share). Oil eased as traders expected US-Iran supply disruptions to lessen; core PCE and Micron earnings are key this week.